Roger E Salisbury, MD Surgery - Plastic and Reconstructive Surgery Medicare: Not Enrolled in Medicare Practice Location: 45 Eastern Point Rd, Gloucester, MA 01930 Phone: 914-438-1752 Fax: 978-282-0977 |
News Archive
Escalating costs and lengthy clinical trials are major concerns for researchers attempting to boost productivity and efficiency in the field of drug discovery. Biomarkers are emerging as the solution to these problems with their ability to reduce drug development costs and time.
The power of regenerative medicine now allows scientists to transform skin cells into cells that closely resemble heart cells, pancreas cells and even neurons. However, a method to generate cells that are fully mature-a crucial prerequisite for life-saving therapies-has proven far more difficult.
AlloCure, Inc. today announced that it has initiated a phase 2 clinical trial of AC607, the company's mesenchymal stem cell therapy, as a potential treatment for acute kidney injury.
Albumedix Ltd. (‘Albumedix'), an enabler of advanced therapies and the world leader in recombinant human albumin (rAlb), announced today that they have entered into a collaboration agreement with Cell and Gene Therapy Catapult (CGT Catapult) to investigate the use of Albumedix´ proprietary albumin-based solutions for advanced therapy applications, including viral vectors manufacturing.
US Spine® announced today that it has been awarded the first patent in a series for its Facet Fixation System. The United States Patent and Trademark Office has assigned patent number 7,563,275 to the Facet Fixation System. US Spine began commercial launch of the system in 2008, which features the Facet Gun™ and Facet Bolt®.
› Verified 9 days ago